Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial

BACKGROUND: MLC601 is a possible modulator of amyloid precursor protein processing, and in a clinical trial study MLC601 showed some effectiveness in cognitive function in Alzheimer's disease (AD) patients. We aimed to evaluate the effectiveness and safety of MLC601 in the treatment of mild to...

Descripción completa

Detalles Bibliográficos
Autores principales: Pakdaman, Hossein, Harandi, Ali Amini, Hatamian, Hamidreza, Tabatabae, Mojgan, Delavar Kasmaei, Hosein, Ghassemi, Amirhossein, Gharagozli, Koroush, Ashrafi, Farzad, Emami Naeini, Pardis, Tavakolian, Mehrnaz, Shahin, Darush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386115/
https://www.ncbi.nlm.nih.gov/pubmed/25873931
http://dx.doi.org/10.1159/000375295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386115/
https://www.ncbi.nlm.nih.gov/pubmed/25873931
http://dx.doi.org/10.1159/000375295

Ejemplares similares